Rezolute Inc (RZLT) Stock Price, Quote & News

Company Profile

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 206 4507

Website: www.rezolutebio.com

Address:

275 Shoreline Drive, Suite 500, Redwood City, United States

Mallardboy Mar. 13 at 9:39 PM

$RZLT why down 14% today?

1 · Reply

KONGLIVES1 Mar. 12 at 12:21 PM

$RZLT any news on the conference in Miami?

0 · Reply

Monty3030 Mar. 9 at 8:37 PM

$RZLT 13.02 days to cover 25.22% short interest

0 · Reply

ZoonieandthePotofMilk Mar. 9 at 8:03 PM

$RZLT This could easily creep back up to $5 before upLIFT data readout.

0 · Reply

KONGLIVES1 Mar. 5 at 6:17 PM

$RZLT we need some volume yesterday‘s up trend was not that strong because of volume and you can see what they’re doing today because of volume. Hopefully the meeting on March 11 in Miami will create some buzz because without any volume we’re dead in the water. good luck to all enjoy the ride.

0 · Reply

Hurricane76 Mar. 5 at 12:20 AM

$RZLT in Miami, next week, there are 5 Biotech 8nvestments banks holding hundreds of meetings between investors and biotechs. So... a meeting with Maxium does not sound like anything big to me... o will say, sounds like its time for an update.

0 · Reply

Smiles_P Mar. 4 at 9:36 PM

$RZLT very…maybe an FDA update between now and then will give them something to talk about…

0 · Reply

PepCF Mar. 4 at 6:56 PM

$RZLT

0 · Reply

KONGLIVES1 Mar. 4 at 4:38 PM

$RZLT hopefully people were buying during this time

0 · Reply

Monty3030 Mar. 3 at 4:16 PM

$RZLT This is interesting....

0 · Reply

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT)

Mar 4, 2026, 7:00 AM EST - 11 days ago

Rezolute to Participate in the Citizens Life Sciences Conference

Mar 3, 2026, 9:10 AM EST - 12 days ago

RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 28, 2026, 7:05 AM EST - 15 days ago

RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 26, 2026, 9:40 AM EST - 17 days ago

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 17, 2026, 7:23 PM EST - 26 days ago

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 12, 2026, 4:05 PM EST - 4 weeks ago

Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update

Feb 10, 2026, 10:51 AM EST - 4 weeks ago

SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 9, 2026, 3:19 PM EST - 4 weeks ago

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating

Feb 5, 2026, 5:09 PM EST - 5 weeks ago

SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Feb 4, 2026, 7:00 AM EST - 5 weeks ago

Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Jan 26, 2026, 3:54 AM EST - 7 weeks ago

Alger Small Cap Growth Fund Q4 2025 Portfolio Update

EXAS GH NBIS NTRA WIX

Jan 25, 2026, 8:21 PM EST - 7 weeks ago

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Jan 16, 2026, 10:27 AM EST - 2 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Jan 8, 2026, 1:12 PM EST - 2 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute

Jan 7, 2026, 7:00 AM EST - 2 months ago

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Jan 3, 2026, 7:41 AM EST - 2 months ago

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

Dec 31, 2025, 12:10 PM EST - 2 months ago

INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

Dec 19, 2025, 10:08 AM EST - 3 months ago

REZOLUTE INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT

Dec 17, 2025, 4:31 PM EST - 3 months ago

RZLT: Rezolute, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Dec 12, 2025, 3:00 PM EST - 3 months ago

RZLT INVESTIGATION: Rezolute, Inc. Investors Should Contact Block & Leviton LLP To Potentially Recover Losses

Dec 11, 2025, 7:59 PM EST - 3 months ago

Hagens Berman Investigating Rezolute, Inc. (RZLT) as Shares Tank 90% Amid Lead Asset Trial Failure

Dec 11, 2025, 2:39 PM EST - 3 months ago

Rezolute, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – RZLT

Dec 11, 2025, 2:22 PM EST - 3 months ago

Rezolute, Inc. (RZLT) Discusses Phase 3 sunRIZE Study Results and Challenges in Congenital Hyperinsulinism Transcript

Dec 11, 2025, 10:39 AM EST - 3 months ago

BREAKING: Rezolute, Inc. Shares Down Over 85%; Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

Dec 11, 2025, 7:05 AM EST - 3 months ago

Rezolute's rare disease drug fails main goal in late-stage trial

Dec 11, 2025, 7:00 AM EST - 3 months ago

Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

Dec 8, 2025, 9:23 PM EST - 3 months ago

Rezolute: sunRIZE And upLIFT Trials Could Drive The Next Move

Nov 10, 2025, 7:51 PM EST - 4 months ago

Rezolute, Inc. (RZLT) Discusses Clinical Progress and Market Opportunity for Ersodetug in Hyperinsulinism Transcript

Nov 10, 2025, 5:30 PM EST - 4 months ago

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nov 6, 2025, 4:05 PM EST - 4 months ago

Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Nov 5, 2025, 7:30 AM EST - 4 months ago

Rezolute to Host Virtual Investor Event on Ersodetug Development Program

Oct 15, 2025, 8:00 AM EDT - 5 months ago

Rezolute to Participate in Upcoming Investor Conferences

Sep 17, 2025, 4:05 PM EDT - 6 months ago

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

Sep 16, 2025, 4:36 PM EDT - 6 months ago

Rezolute: FDA Pivotal Trial Alignment Change Further Bolsters Ersodetug

Sep 12, 2025, 9:38 AM EDT - 6 months ago

Rezolute, Inc. (RZLT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 7:30 AM EDT - 6 months ago

Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism

Aug 20, 2025, 7:30 AM EDT - 7 months ago

Rezolute Appoints Seasoned Commercial Executive Sunil Karnawat as Chief Commercial Officer

Jul 22, 2025, 7:30 AM EDT - 8 months ago

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Mallardboy Mar. 13 at 9:39 PM

$RZLT why down 14% today?

1 · Reply

KONGLIVES1 Mar. 12 at 12:21 PM

$RZLT any news on the conference in Miami?

0 · Reply

Monty3030 Mar. 9 at 8:37 PM

$RZLT 13.02 days to cover 25.22% short interest

0 · Reply

ZoonieandthePotofMilk Mar. 9 at 8:03 PM

$RZLT This could easily creep back up to $5 before upLIFT data readout.

0 · Reply

KONGLIVES1 Mar. 5 at 6:17 PM

0 · Reply

Hurricane76 Mar. 5 at 12:20 AM

0 · Reply

Smiles_P Mar. 4 at 9:36 PM

$RZLT very…maybe an FDA update between now and then will give them something to talk about…

0 · Reply

PepCF Mar. 4 at 6:56 PM

$RZLT

0 · Reply

KONGLIVES1 Mar. 4 at 4:38 PM

$RZLT hopefully people were buying during this time

0 · Reply

Monty3030 Mar. 3 at 4:16 PM

$RZLT This is interesting....

0 · Reply

KONGLIVES1 Mar. 2 at 10:18 AM

$RZLT this will be another buying opportunity as they always are $100 oil 😂😂😂😂😂 good luck enjoy the ride

0 · Reply

KONGLIVES1 Mar. 2 at 10:14 AM

$RZLT please (oil) the average oil price under Biden was $80 so please sell it somewhere else. Good luck and enjoy the ride.

0 · Reply

prismmarketview Feb. 26 at 5:56 PM

Investing in Innovation during Rare Disease Day 2026 $LRMR $ZVRA $FENC $RZLT $IRD Investing in Innovation during Rare Disease Day 2026 https://prismmarketview.com/investing-in-innovation-during-rare-disease-day-2026/

0 · Reply

Chefbyday Feb. 25 at 2:32 AM

$RZLT WEEEEEE 🙌🏻

0 · Reply

niock Feb. 24 at 7:27 PM

$RZLT when you consider this go up or down?

0 · Reply

oaksapollo Feb. 24 at 7:12 PM

$RZLT this is a few weeks old but I just came across it today https://www.statnews.com/sponsor/2026/02/09/the-conundrum-of-false-negative-clinical-studies-in-ultra-rare-diseases/ Basically a paid advertisement. Can't say I'm a huge fan of this approach but fwiw.

0 · Reply

EvCe Feb. 23 at 9:09 AM

$RZLT

0 · Reply

OfficialStocktwitsUser Feb. 21 at 6:38 PM

$RZLT RSI: 48.78, MACD: 0.0085 Vol: 0.24, MA20: 3.33, MA50: 3.05 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Monty3030 Feb. 21 at 4:17 AM

$RZLT New Update 11.32 Days to Cover 26.68% Short Interest

0 · Reply

Monty3030 Feb. 20 at 5:40 PM

$RZLT Short Interest Ratio 7.14 Days to Cover Short Interest % Float 26.68 %

0 · Reply

EvCe Feb. 20 at 8:52 AM

$RZLT uh oh …adding … slow long run

0 · Reply

Market Cap	248.34M
Revenue (ttm)	0.00
Net Income (ttm)	-74.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	3,280,800
Avg Vol	3,172,642
Day's Range	N/A - N/A
Shares Out	95.70M
Stochastic %K	3%
Beta	0.51
Analysts	Strong Sell
Price Target	$4.75